{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T18:43:39Z","timestamp":1777747419385,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Melanoma has the highest mortality rate of all skin tumors, and metastases are the major cause of death from it. The molecular mechanism leading to melanoma metastasis is currently unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>With the goal of revealing the underlying mechanism, three data sets with accession numbers GSE8401, GSE46517 and GSE7956 were downloaded from the Gene Expression Omnibus (GEO) database. After identifying the differentially expressed gene (DEG) of primary melanoma and metastatic melanoma, three kinds of analyses were performed, namely functional annotation, protein-protein interaction (PPI) network and module construction, and co-expression and drug-gene interaction prediction analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 41 up-regulated genes and 79 down-regulated genes was selected for subsequent analyses. Results of pathway enrichment analysis showed that extracellular matrix organization and proteoglycans in cancer are closely related to melanoma metastasis. In addition, seven pivotal genes were identified from PPI network, including CXCL8, THBS1, COL3A1, TIMP3, KIT, DCN, and IGFBP5, which have all been verified in the TCGA database and clinical specimens, but only CXCL8, THBS1 and KIT had significant differences in expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>To conclude, CXCL8, THBS1 and KIT may be the hub genes in the metastasis of melanoma and thus may be regarded as therapeutic targets in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-07372-5","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T09:02:47Z","timestamp":1599469367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Bioinformatic analysis reveals hub genes and pathways that promote melanoma metastasis"],"prefix":"10.1186","volume":"20","author":[{"given":"Wenxing","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanjuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daojiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longjiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,7]]},"reference":[{"issue":"1","key":"7372_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"7372_CR2","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.cell.2006.06.008","volume":"125","author":"M Kim","year":"2006","unstructured":"Kim M, Gans JD, Nogueira C, Wang A, Paik JH, Feng B, Brennan C, Hahn WC, Cordon-Cardo C, Wagner SN, et al. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell. 2006;125(7):1269\u201381.","journal-title":"Cell"},{"issue":"20","key":"7372_CR3","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1200\/JCO.2011.41.2452","volume":"30","author":"M Colombino","year":"2012","unstructured":"Colombino M, Capone M, Lissia A, Cossu A, Rubino C, De Giorgi V, Massi D, Fonsatti E, Staibano S, Nappi O, et al. BRAF\/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma. J Clin Oncol. 2012;30(20):2522\u20139.","journal-title":"J Clin Oncol"},{"issue":"16","key":"7372_CR4","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1002\/cncr.26724","volume":"118","author":"JA Jakob","year":"2012","unstructured":"Jakob JA, Bassett RL Jr, Ng CS, Curry JL, Joseph RW, Alvarado GC, Rohlfs ML, Richard J, Gershenwald JE, Kim KB, et al. NRAS mutation status is an independent prognostic factor in metastatic melanoma. Cancer. 2012;118(16):4014\u201323.","journal-title":"Cancer"},{"issue":"6122","key":"7372_CR5","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1126\/science.1229259","volume":"339","author":"FW Huang","year":"2013","unstructured":"Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA. Highly recurrent TERT promoter mutations in human melanoma. Science. 2013;339(6122):957\u20139.","journal-title":"Science"},{"issue":"16","key":"7372_CR6","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1093\/nar\/28.16.3011","volume":"28","author":"J Wang","year":"2000","unstructured":"Wang J. From DNA biosensors to gene chips. Nucleic Acids Res. 2000;28(16):3011\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"7372_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207\u201310.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"7372_CR8","first-page":"D991","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, et al. NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013;41(Database issue):D991\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"7372_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang Da","year":"2009","unstructured":"Huang Da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44\u201357.","journal-title":"Nat Protoc"},{"issue":"15","key":"7372_CR10","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1002\/pmic.201400515","volume":"15","author":"M Pathan","year":"2015","unstructured":"Pathan M, Keerthikumar S, Ang C-S, Gangoda L, Quek CYJ, Williamson NA, Mouradov D, Sieber OM, Simpson RJ, Salim A, et al. FunRich: an open access standalone functional enrichment and interaction network analysis tool. Proteomics. 2015;15(15):2597\u2013601.","journal-title":"Proteomics"},{"issue":"Web Server issu","key":"7372_CR11","doi-asserted-by":"publisher","first-page":"W720","DOI":"10.1093\/nar\/gkl167","volume":"34","author":"J Wu","year":"2006","unstructured":"Wu J, Mao X, Cai T, Luo J, Wei L. KOBAS server: a web-based platform for automated annotation and pathway identification. Nucleic Acids Res. 2006;34(Web Server issue):W720\u20134.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"7372_CR12","first-page":"D808","volume":"41","author":"A Franceschini","year":"2013","unstructured":"Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C, et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013;41(Database issue):D808\u201315.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"7372_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/bioinformatics\/btq675","volume":"27","author":"ME Smoot","year":"2011","unstructured":"Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2011;27(3):431\u20132.","journal-title":"Bioinformatics"},{"key":"7372_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.biosystems.2014.11.005","volume":"127","author":"Y Tang","year":"2015","unstructured":"Tang Y, Li M, Wang J, Pan Y, Wu F-X. CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Biosystems. 2015;127:67\u201372.","journal-title":"Biosystems"},{"key":"7372_CR15","doi-asserted-by":"crossref","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist\u2011oriented resource for the analysis of systems\u2011level datasets. Nat Commun. 2019;10(1):1523.","DOI":"10.1038\/s41467-019-09234-6"},{"issue":"Web Server issu","key":"7372_CR16","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38(Web Server issue):W214\u201320.","journal-title":"Nucleic Acids Res"},{"key":"7372_CR17","doi-asserted-by":"crossref","unstructured":"Cotto K, Wagner A, Feng Y-Y, Kiwala S, Coffman A, Spies G, Wollam A, Spies N, Griffith O, Griffith M: DGIdb 3.0: a redesign and expansion of the drug-gene interaction database. In.: bioRxiv; 2017.","DOI":"10.1101\/200527"},{"issue":"5957","key":"7372_CR18","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1126\/science.1176009","volume":"326","author":"RO Hynes","year":"2009","unstructured":"Hynes RO. The extracellular matrix: not just pretty fibrils. Science. 2009;326(5957):1216\u20139.","journal-title":"Science"},{"issue":"1","key":"7372_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1158\/2159-8290.CD-18-0193","volume":"9","author":"A Kaur","year":"2019","unstructured":"Kaur A, Ecker BL, Douglass SM, Kugel CH 3rd, Webster MR, Almeida FV, Somasundaram R, Hayden J, Ban E, Ahmadzadeh H, et al. Remodeling of the collagen matrix in aging skin promotes melanoma metastasis and affects immune cell motility. Cancer Discov. 2019;9(1):64\u201381.","journal-title":"Cancer Discov"},{"issue":"21","key":"7372_CR20","doi-asserted-by":"publisher","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","volume":"14","author":"DJ Waugh","year":"2008","unstructured":"Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res. 2008;14(21):6735\u201341.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"7372_CR21","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1038\/sj.bjc.6605055","volume":"100","author":"S Singh","year":"2009","unstructured":"Singh S, Nannuru KC, Sadanandam A, Varney ML, Singh RK. CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion. Br J Cancer. 2009;100(10):1638\u201346.","journal-title":"Br J Cancer"},{"issue":"2","key":"7372_CR22","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/ijc.24714","volume":"126","author":"S Singh","year":"2010","unstructured":"Singh S, Sadanandam A, Varney ML, Nannuru KC, Singh RK. Small interfering RNA-mediated CXCR1 or CXCR2 knock-down inhibits melanoma tumor growth and invasion. Int J Cancer. 2010;126(2):328\u201336.","journal-title":"Int J Cancer"},{"issue":"2","key":"7372_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1309\/VPL5R3JR7F1D6V03","volume":"125","author":"ML Varney","year":"2006","unstructured":"Varney ML, Johansson SL, Singh RK. Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma. Am J Clin Pathol. 2006;125(2):209\u201316.","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"7372_CR24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1158\/0008-5472.CAN-08-3378","volume":"69","author":"S Singh","year":"2009","unstructured":"Singh S, Varney M, Singh RK. Host CXCR2-dependent regulation of melanoma growth, angiogenesis, and experimental lung metastasis. Cancer Res. 2009;69(2):411\u20135.","journal-title":"Cancer Res"},{"issue":"3","key":"7372_CR25","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/cam4.28","volume":"1","author":"S Wu","year":"2012","unstructured":"Wu S, Singh S, Varney ML, Kindle S, Singh RK. Modulation of CXCL-8 expression in human melanoma cells regulates tumor growth, angiogenesis, invasion, and metastasis. Cancer Med. 2012;1(3):306\u201317.","journal-title":"Cancer Med"},{"issue":"5","key":"7372_CR26","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s00018-007-7484-1","volume":"65","author":"CB Carlson","year":"2008","unstructured":"Carlson CB, Lawler J, Mosher DF. Structures of thrombospondins. Cellular and molecular life sciences : CMLS. 2008;65(5):672\u201386.","journal-title":"Cellular and molecular life sciences : CMLS"},{"issue":"6","key":"7372_CR27","doi-asserted-by":"publisher","first-page":"12249","DOI":"10.3390\/ijms140612249","volume":"14","author":"Y Miyata","year":"2013","unstructured":"Miyata Y, Sakai H. Thrombospondin-1 in urological cancer: pathological role, clinical significance, and therapeutic prospects. Int J Mol Sci. 2013;14(6):12249\u201372.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"7372_CR28","doi-asserted-by":"publisher","first-page":"e49419","DOI":"10.1371\/journal.pone.0049419","volume":"7","author":"M Wehbe","year":"2012","unstructured":"Wehbe M, Soudja SM, Mas A, Chasson L, Guinamard R, de Tenbossche CP, Verdeil G, Van den Eynde B, Schmitt-Verhulst AM. Epithelial-mesenchymal-transition-like and TGFbeta pathways associated with autochthonous inflammatory melanoma development in mice. PLoS One. 2012;7(11):e49419.","journal-title":"PLoS One"},{"issue":"4","key":"7372_CR29","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ccr.2013.08.018","volume":"24","author":"J Caramel","year":"2013","unstructured":"Caramel J, Papadogeorgakis E, Hill L, Browne GJ, Richard G, Wierinckx A, Saldanha G, Osborne J, Hutchinson P, Tse G, et al. A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell. 2013;24(4):466\u201380.","journal-title":"Cancer Cell"},{"key":"7372_CR30","first-page":"97","volume":"4","author":"JE Kim","year":"2013","unstructured":"Kim JE, Leung E, Baguley BC, Finlay GJ. Heterogeneity of expression of epithelial-mesenchymal transition markers in melanocytes and melanoma cell lines. Front Genet. 2013;4:97.","journal-title":"Front Genet"},{"issue":"12","key":"7372_CR31","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/ki.2012.21","volume":"81","author":"N Bige","year":"2012","unstructured":"Bige N, Shweke N, Benhassine S, Jouanneau C, Vandermeersch S, Dussaule JC, Chatziantoniou C, Ronco P, Boffa JJ. Thrombospondin-1 plays a profibrotic and pro-inflammatory role during ureteric obstruction. Kidney Int. 2012;81(12):1226\u201338.","journal-title":"Kidney Int"},{"issue":"1","key":"7372_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/abbs\/gmx123","volume":"50","author":"F Xie","year":"2018","unstructured":"Xie F, Ling L, van Dam H, Zhou F, Zhang L. TGF-beta signaling in cancer metastasis. Acta Biochim Biophys Sin. 2018;50(1):121\u201332.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"14","key":"7372_CR33","doi-asserted-by":"publisher","first-page":"5782","DOI":"10.18632\/oncotarget.2164","volume":"5","author":"A Jayachandran","year":"2014","unstructured":"Jayachandran A, Anaka M, Prithviraj P, Hudson C, McKeown SJ, Lo PH, Vella LJ, Goding CR, Cebon J, Behren A. Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma. Oncotarget. 2014;5(14):5782\u201397.","journal-title":"Oncotarget"},{"issue":"1","key":"7372_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/pcmr.12319","volume":"28","author":"P Borsotti","year":"2015","unstructured":"Borsotti P, Ghilardi C, Ostano P, Silini A, Dossi R, Pinessi D, Foglieni C, Scatolini M, Lacal PM, Ferrari R, et al. Thrombospondin-1 is part of a slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2. Pigment Cell Melanoma Res. 2015;28(1):73\u201381.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"2","key":"7372_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1046\/j.1523-1747.1998.00272.x","volume":"111","author":"JM Grichnik","year":"1998","unstructured":"Grichnik JM, Burch JA, Burchette J, Shea CR. The SCF\/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis. J Invest Dermatol. 1998;111(2):233\u20138.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"7372_CR36","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/sj.jid.5700125","volume":"126","author":"V Alexeev","year":"2006","unstructured":"Alexeev V, Yoon K. Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes. J Invest Dermatol. 2006;126(5):1102\u201310.","journal-title":"J Invest Dermatol"},{"issue":"11","key":"7372_CR37","first-page":"2339","volume":"13","author":"S Huang","year":"1996","unstructured":"Huang S, Luca M, Gutman M, McConkey DJ, Langley KE, Lyman SD, Bar-Eli M. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential. Oncogene. 1996;13(11):2339\u201347.","journal-title":"Oncogene"},{"issue":"9","key":"7372_CR38","first-page":"939","volume":"10","author":"KT Montone","year":"1997","unstructured":"Montone KT, van Belle P, Elenitsas R, Elder DE. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression. Mod Pathol. 1997;10(9):939\u201344.","journal-title":"Mod Pathol"},{"issue":"2","key":"7372_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/ijc.2910520207","volume":"52","author":"PG Natali","year":"1992","unstructured":"Natali PG, Nicotra MR, Winkler AB, Cavaliere R, Bigotti A, Ullrich A. Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor. Int J Cancer. 1992;52(2):197\u2013201.","journal-title":"Int J Cancer"},{"issue":"8","key":"7372_CR40","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.humpath.2013.01.007","volume":"44","author":"B Dai","year":"2013","unstructured":"Dai B, Cai X, Kong Y-Y, Yang F, Shen X-X, Wang L-W, Kong J-C. Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases\/recurrences. Hum Pathol. 2013;44(8):1472\u20138.","journal-title":"Hum Pathol"},{"issue":"7","key":"7372_CR41","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1158\/1078-0432.CCR-10-2346","volume":"17","author":"Y Kong","year":"2011","unstructured":"Kong Y, Si L, Zhu Y, Xu X, Corless CL, Flaherty KT, Li L, Li H, Sheng X, Cui C, et al. Large-scale analysis of KIT aberrations in Chinese patients with melanoma. Clin Cancer Res. 2011;17(7):1684\u201391.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"7372_CR42","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1093\/annonc\/mdx079","volume":"28","author":"J Guo","year":"2017","unstructured":"Guo J, Carvajal RD, Dummer R, Hauschild A, Daud A, Bastian BC, Markovic SN, Queirolo P, Arance A, Berking C, et al. Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial. Ann Oncol. 2017;28(6):1380\u20137.","journal-title":"Ann Oncol"},{"issue":"22","key":"7372_CR43","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1001\/jama.2011.746","volume":"305","author":"RD Carvajal","year":"2011","unstructured":"Carvajal RD, Antonescu CR, Wolchok JD, Chapman PB, Roman R-A, Teitcher J, Panageas KS, Busam KJ, Chmielowski B, Lutzky J, et al. KIT as a therapeutic target in metastatic melanoma. JAMA. 2011;305(22):2327\u201334.","journal-title":"JAMA"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07372-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07372-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07372-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T19:14:39Z","timestamp":1630955679000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07372-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,7]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7372"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07372-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-25246\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-25246\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-25246\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-25246\/v4","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,7]]},"assertion":[{"value":"24 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The informed consent of all patients has been obtained before the operation, and the procedures for organizing collection have been approved by the Ethics Committee of the Second Affiliated Hospital of Soochow University, China. All procedures comply with the guidelines and ethical principles outlined in the Helsinki Declaration.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"863"}}